Ignite Creation Date:
2024-05-05 @ 6:35 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00504192
Status:
COMPLETED
Last Update Posted:
2014-05-20
First Post:
2007-07-18
Brief Title:
A Phase II Study of Gemcitabine With Oxaliplatin as First Line Chemotherapy in Advanced Biliary Tract Cancer
Sponsor:
Soonchunhyang University Hospital
Organization:
Soonchunhyang University Hospital
Organization Data
Organization:
Soonchunhyang University Hospital
Class:
OTHER
Study ID:
SCH-GO-BTC1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Soonchunhyang University Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Dae Sik Hong
Old Organization:
Soonchunhyang Bucheon Hospital